Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.31 USD | -1.22% | +2.49% | +71.88% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 429M |
---|---|---|---|---|---|
Net income 2024 * | -66M | Net income 2025 * | -76M | EV / Sales 2024 * | - |
Net cash position 2024 * | 327M | Net cash position 2025 * | 501M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-9.12
x | P/E ratio 2025 * |
-9.28
x | Employees | 91 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.22% |
Latest transcript on Neurogene Inc.
1 day | -1.22% | ||
1 week | +2.49% | ||
Current month | -3.39% | ||
1 month | +5.48% | ||
3 months | +13.07% | ||
Current year | +71.88% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 33.31 | -1.22% | 49,599 |
24-05-16 | 33.72 | +0.39% | 57,033 |
24-05-15 | 33.59 | +6.47% | 51,187 |
24-05-14 | 31.55 | +2.97% | 82,957 |
24-05-13 | 30.64 | -5.72% | 47,541 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+71.88% | 429M | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- NGNE Stock